Mostrar el registro sencillo del ítem

dc.contributor.authorGómez-Sánchez, Jose C
dc.contributor.authorDelgado-Esteban, María
dc.contributor.authorRodríguez-Hernández, Irene
dc.contributor.authorSobrino Moreiras, Tomas 
dc.contributor.authorPérez de la Ossa, Natalia
dc.contributor.authorReverte, Silvia
dc.contributor.authorBolaños, Juan P.
dc.contributor.authorGonzález-Sarmiento, Rogelio
dc.contributor.authorCastillo Sánchez, José 
dc.contributor.authorAlmeida, Ángeles
dc.date.accessioned2017-06-07T07:23:38Z
dc.date.available2017-06-07T07:23:38Z
dc.date.issued2011
dc.identifier.issn0022-1007
dc.identifier.urihttp://hdl.handle.net/20.500.11940/5893
dc.description.abstractThe functional outcome after stroke is unpredictable; it is not accurately predicted by clinical pictures upon hospital admission. The presence of apoptotic neurons in the ischemic penumbra and perihematoma area may account for poor prognosis, but whether the highly variable stroke outcome reflects differences in genetic susceptibility to apoptosis is elusive. The p53 tumor suppressor protein, an important transcriptional regulator of apoptosis, naturally occurs in humans in two variants with single nucleotide polymorphisms resulting in Arg or Pro at residue 72. We show that poor functional outcome after either ischemic or hemorrhagic stroke was linked to the Arg/Arg genotype. This genotype was also associated with early neurological deterioration in ischemic stroke and with increased residual cavity volume in intracerebral hemorrhage. In primary cultured neurons, Arg(72)-p53, but not Pro(72)-p53, interacted directly with mitochondrial Bcl-xL and activated the intrinsic apoptotic pathway, increasing vulnerability to ischemia-induced apoptotic cell death. These results suggest that the Tp53 Arg/Arg genotype governs neuronal vulnerability to apoptosis and can be considered as a genetic marker predicting poor functional outcome after stroke.
dc.language.isoeng
dc.titleThe human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke
dc.typeArtigoes
dc.authorsophosGomez-Sanchez, Jose C.
dc.authorsophosDelgado-Esteban, Maria
dc.authorsophosRodriguez-Hernandez, Irene
dc.authorsophosSobrino, Tomas
dc.authorsophosPerez de la Ossa, Natalia
dc.authorsophosReverte, Silvia
dc.authorsophosBolanos, Juan P.
dc.authorsophosGonzalez-Sarmiento, Rogelio
dc.authorsophosCastillo, Jose
dc.authorsophosAlmeida, Angeles
dc.authorsophosJ.C., Gomez-Sanchez
dc.authorsophosM., Delgado-Esteban
dc.authorsophosI., Rodriguez-Hernandez
dc.authorsophosT., Sobrino
dc.authorsophosN.P., De La Ossa
dc.authorsophosS., Reverte
dc.authorsophosJ.P., Bolanos
dc.authorsophosR., Gonzalez-Sarmiento
dc.authorsophosJ., Castillo
dc.authorsophosA., Almeida
dc.identifier.doi10.1084/jem.20101523
dc.identifier.pmid21357744
dc.identifier.sophos10327
dc.issue.number3
dc.journal.titleJOURNAL OF EXPERIMENTAL MEDICINE
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Neuroloxía
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago
dc.page.initial429
dc.page.final437
dc.rights.accessRightsopenAccess
dc.typesophosArtículo Original
dc.volume.number208


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem